Marco
de indicadores mundiales para los Objetivos de Desarrollo Sostenible y metas de
la Agenda 2030 para el Desarrollo Sostenible
Global
indicator framework for the Sustainable Development Goals and targets of the
2030 Agenda for Sustainable Development
03. SALUD Y BIENESTAR GOOD HEALTH AND WELL-BEING
Garantizar una vida sana y promover el bienestar de todos a todas las edades
Ensure healthy lives and promote well-being for all at all ages
Garantizar una vida sana y promover el bienestar de todos a todas las edades
Ensure healthy lives and promote well-being for all at all ages
3.1 De aquí a 2030, reducir la tasa
mundial de mortalidad materna a menos de 70 por cada 100.000 nacidos vivos
3.1 By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births
3.1 By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births
3.1.1 Tasa de mortalidad materna
3.1.1 Maternal mortality ratio
3.1.1 Maternal mortality ratio
3.1.2 Proporción de partos atendidos por
personal sanitario especializado
3.1.2 Proportion of births attended by skilled health personnel
3.1.2 Proportion of births attended by skilled health personnel
3.2 De aquí a 2030, poner fin a las
muertes evitables de recién nacidos y de niños menores de 5 años, logrando que
todos los países intenten reducir la mortalidad neonatal al menos a 12 por cada
1.000 nacidos vivos y la mortalidad de los niños menores de 5 años al menos a
25 por cada 1.000 nacidos vivos
3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births
3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births
3.2.1 Tasa de mortalidad de niños menores de
5 años
3.2.1 Under-5 mortality rate
3.2.1 Under-5 mortality rate
3.2.2 Tasa de mortalidad neonatal
3.2.2 Neonatal mortality rate
3.2.2 Neonatal mortality rate
3.3 De aquí a 2030, poner fin a las
epidemias del SIDA, la tuberculosis, la malaria y las enfermedades tropicales
desatendidas y combatir la hepatitis, las enfermedades transmitidas por el agua
y otras enfermedades transmisibles
3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
3.3.1 Número de nuevas infecciones por el
VIH por cada 1.000 habitantes no infectados, desglosado por sexo, edad y poblaciones
clave
3.3.1 Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations
3.3.1 Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations
3.3.2 Incidencia de la tuberculosis por cada
100.000 habitantes
3.3.2 Tuberculosis incidence per 100,000 population
3.3.2 Tuberculosis incidence per 100,000 population
3.3.3 Incidencia de la malaria por cada
1.000 habitantes
3.3.3 Malaria incidence per 1,000 population
3.3.3 Malaria incidence per 1,000 population
3.3.4 Incidencia de la hepatitis B por cada
100.000 habitantes
3.3.4 Hepatitis B incidence per 100,000 population
3.3.4 Hepatitis B incidence per 100,000 population
3.3.5 Número de personas que requieren
intervenciones contra enfermedades tropicales desatendidas
3.3.5 Number of people requiring interventions against neglected tropical diseases
3.3.5 Number of people requiring interventions against neglected tropical diseases
3.4 De aquí a 2030, reducir en un tercio
la mortalidad prematura por enfermedades no transmisibles mediante su
prevención y tratamiento, y promover la salud mental y el bienestar
3.4 By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being
3.4 By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being
3.4.1 Tasa de mortalidad atribuida a las
enfermedades cardiovasculares, el cáncer, la diabetes o las enfermedades
respiratorias crónicas
3.4.1 Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
3.4.1 Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
3.4.2 Tasa de mortalidad por suicidio
3.4.2 Suicide mortality rate
3.4.2 Suicide mortality rate
3.5 Fortalecer la prevención y el
tratamiento del abuso de sustancias adictivas, incluido el uso indebido de
estupefacientes y el consumo nocivo de alcohol
3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol
3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol
3.5.1 Cobertura de los tratamientos (farmacológicos
y psicosociales y servicios de rehabilitación y postratamiento) de trastornos
por abuso de sustancias adictivas
3.5.1 Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders
3.5.1 Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders
3.5.2 Consumo nocivo de alcohol, definido
según el contexto nacional como el consumo de alcohol per cápita (a partir de
los 15 años de edad) durante un año civil en litros de alcohol puro
3.5.2 Harmful use of alcohol, defined according to the national context as alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcohol
3.5.2 Harmful use of alcohol, defined according to the national context as alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcohol
3.6 De aquí a 2020, reducir a la mitad
el número de muertes y lesiones causadas por accidentes de tráfico en el mundo
3.6 By 2020, halve the number of global deaths and injuries from road traffic accidents
3.6 By 2020, halve the number of global deaths and injuries from road traffic accidents
3.6.1 Tasa de mortalidad por lesiones
debidas a accidentes de tráfico
3.6.1 Death rate due to road traffic injuries
3.6.1 Death rate due to road traffic injuries
3.7 De aquí a 2030, garantizar el acceso
universal a los servicios de salud sexual y reproductiva, incluidos los de
planificación familiar, información y educación, y la integración de la salud
reproductiva en las estrategias y los programas nacionales
3.7 By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes
3.7 By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes
3.7.1 Proporción de mujeres en edad de
procrear (entre 15 y 49 años) que cubren sus necesidades de planificación
familiar con métodos modernos
3.7.1 Proportion of women of reproductive age (aged 15–49 years) who have their need for family planning satisfied with modern methods
3.7.1 Proportion of women of reproductive age (aged 15–49 years) who have their need for family planning satisfied with modern methods
3.7.2 Tasa de fecundidad de las adolescentes
(entre 10 y 14 años y entre 15 y 19 años) por cada 1.000 mujeres de ese grupo
de edad
3.7.2 Adolescent birth rate (aged 10–14 years; aged 15–19 years) per 1,000 women in that age group
3.7.2 Adolescent birth rate (aged 10–14 years; aged 15–19 years) per 1,000 women in that age group
3.8 Lograr la cobertura sanitaria
universal, incluida la protección contra los riesgos financieros, el acceso a
servicios de salud esenciales de calidad y el acceso a medicamentos y vacunas
inocuos, eficaces, asequibles y de calidad para todos
3.8 Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all
3.8 Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all
3.8.1 Cobertura de los servicios de salud
esenciales (definida como la cobertura media de los servicios esenciales entre
la población general y los más desfavorecidos, calculada a partir de
intervenciones trazadoras como las relacionadas con la salud reproductiva,
materna, neonatal e infantil, las enfermedades infecciosas, las enfermedades no
transmisibles y la capacidad de los servicios y el acceso a ellos)
3.8.1 Coverage of essential health services (defined as the average coverage of essential services based on tracer interventions that include reproductive, maternal, newborn and child health, infectious diseases, non-communicable diseases and service capacity and access, among the general and the most disadvantaged population)
3.8.1 Coverage of essential health services (defined as the average coverage of essential services based on tracer interventions that include reproductive, maternal, newborn and child health, infectious diseases, non-communicable diseases and service capacity and access, among the general and the most disadvantaged population)
3.8.2 Proporción de la población con
grandes gastos sanitarios por hogar como porcentaje del total de gastos o
ingresos de los hogares
3.8.2 Proportion of population with large household expenditures on health as a share of total household expenditure or income
3.8.2 Proportion of population with large household expenditures on health as a share of total household expenditure or income
3.9 De aquí a 2030, reducir
considerablemente el número de muertes y enfermedades causadas por productos
químicos peligrosos y por la polución y contaminación del aire, el agua y el
suelo
3.9 By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination
3.9 By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination
3.9.1 Tasa de mortalidad atribuida a la
contaminación de los hogares y del aire ambiente
3.9.1 Mortality rate attributed to household and ambient air pollution
3.9.1 Mortality rate attributed to household and ambient air pollution
3.9.2 Tasa de mortalidad atribuida al agua
insalubre, el saneamiento deficiente y la falta de higiene (exposición a
servicios insalubres de agua, saneamiento e higiene para todos (WASH))
3.9.2 Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (exposure to unsafe Water, Sanitation and Hygiene for All (WASH) services)
3.9.2 Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (exposure to unsafe Water, Sanitation and Hygiene for All (WASH) services)
3.a Fortalecer la aplicación del
Convenio Marco de la Organización Mundial de la Salud para el Control del
Tabaco en todos los países, según proceda
3.a Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate
3.a Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate
3.a.1 Prevalencia del consumo actual de
tabaco a partir de los 15 años de edad (edades ajustadas)
3.a.1 Age-standardized prevalence of current tobacco use among persons aged 15 years and older
3.a.1 Age-standardized prevalence of current tobacco use among persons aged 15 years and older
3.b Apoyar las actividades de
investigación y desarrollo de vacunas y medicamentos contra las enfermedades
transmisibles y no transmisibles que afectan primordialmente a los países en
desarrollo y facilitar el acceso a medicamentos y vacunas esenciales asequibles
de conformidad con la Declaración relativa al Acuerdo sobre los Aspectos de los
Derechos de Propiedad Intelectual Relacionados con el Comercio y la Salud
Pública, en la que se afirma el derecho de los países en desarrollo a utilizar
al máximo las disposiciones del Acuerdo sobre los Aspectos de los Derechos de
Propiedad Intelectual Relacionados con el Comercio respecto a la flexibilidad
para proteger la salud pública y, en particular, proporcionar acceso a los
medicamentos para todos
3.b Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
3.b Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
3.b.1 Proporción de la población inmunizada
con todas las vacunas incluidas en cada programa nacional
3.b.1 Proportion of the target population covered by all vaccines included in their national programme
3.b.1 Proportion of the target population covered by all vaccines included in their national programme
3.b.2 Total neto de asistencia oficial para
el desarrollo destinado a los sectores de la investigación médica y la atención
sanitaria básica
3.b.2 Total net official development assistance to medical research and basic health sectors
3.b.2 Total net official development assistance to medical research and basic health sectors
3.b.3 Proporción de centros de salud que
disponen de un conjunto básico de medicamentos esenciales asequibles de manera
sostenible
3.b.3 Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis
3.b.3 Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis
3.c Aumentar considerablemente la
financiación de la salud y la contratación, el perfeccionamiento, la
capacitación y la retención del personal sanitario en los países en desarrollo,
especialmente en los países menos adelantados y los pequeños Estados insulares
en desarrollo
3.c Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States
3.c Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States
3.c.1 Densidad y distribución del personal
sanitario
3.c.1 Health worker density and distribution
3.c.1 Health worker density and distribution
3.d Reforzar la capacidad de todos los
países, en particular los países en desarrollo, en materia de alerta temprana,
reducción de riesgos y gestión de los riesgos para la salud nacional y mundial
3.d Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks
3.d Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks
3.d.1 Capacidad prevista en el Reglamento
Sanitario Internacional (RSI) y preparación para emergencias de salud
3.d.1 International Health Regulations (IHR) capacity and health emergency preparedness
3.d.1 International Health Regulations (IHR) capacity and health emergency preparedness
REFERENCIAS
A/RES/71/313. Labor de la Comisión de Estadística
en relación con la Agenda2030 para el Desarrollo Sostenible (10/07/2017)
A/RES/71/313. Work of the Statistical Commission pertaining to the 2030 Agenda for
Sustainable Development (10/07/2017)
No hay comentarios:
Publicar un comentario